Optimizing Biologics Testing
Less than 1 percent of all drug candidates entering clinical trials reach the market, which means you need a partner with a proven track record. With over 40,000 tests run annually at global biologics testing facilities and 200+ products supported; Charles River can provide comprehensive testing services for a wide range of modalities. These include monoclonal antibodies/recombinant proteins, viral vectors, vaccines, and cell therapies. Count on us to ensure your biologic is safe, effective, and able to pass regulatory scrutiny.
Next Generation Sequencing is the modern solution best suited to the complexities of developing donor-derived cell therapies, offering many advantages over traditional Polymerase Chain Reaction.
This brochure will expand on our NGS testing services to biopharmaceutical and biotech companies, including viral contamination testing and genetic characterization of cell lines, bulk harvests, virus seeds, and raw materials used for production of biologics including cell and gene therapy products.
In this series of presentations, experts from Takeda, Charles River, and PathoQuest discuss the current state of viral safety testing and the emergence of broad molecular methods, such as Next-Generation Sequencing (NGS), that address some of the gaps in traditional viral safety testing of biologics.
Topics included new strategies for viral clearance, NGS applications for viral safety testing, and more. Get all the insights in this easy-to-digest eBook.
Join this webinar to learn why viral clearance testing of medical devices is critical for compliance and safety, how testing strategies can impact study effectiveness, and how to avoid regulatory hurdles.
Your biologic can only be as successful as the cells behind it. Learn about our full spectrum of CGMP cell banking and cell line characterization services.
Learn about developing potency assays and gaining knowledge about mechanisms of action (MOAs) early in the drug development process.
In this on-demand webinar, cell banking and cell line characterization experts share why HEK293 cells are important for viral vector production for CGT products.
